Claris Lifesciences Ltd (CLAI.BO)
19 Oct 2017
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|78||2012||Non-Executive Independent Chairman of the Board|
|2014||Vice Chairman of the Board, Chief Executive Officer, Managing Director|
|2013||Compliance Officer, Company Secretary|
|Whole Time Director|
|2014||Non Executive Non Independent Woman Director|
- BRIEF-RBI hikes foreign investment limit in Claris Lifesciences to 49 pct
- BRIEF-Claris Lifesciences completes stake sale in JV to Otsuka
- BRIEF-Claris Lifesciences gets shareholders' nod to raise FII/FPI shareholding limits in co
- BRIEF-India's Claris Lifesciences June-qtr consol profit down 13 pct
- U.S. FTC approves Baxter's acquisition of Claris business with condition